Share

April 10, 2018; 90 (15 Supplement) April 27, 2018

Memantine and Cholinesterase Inhibitor Use in Alzheimer Disease Trials: Potential for Confounding by Indication (P6.178)

Branko Huisa, Ronald Thomas, Shelia Jin, Tilman Oltersdorf, Curtis Taylor, Howard Feldman
First published April 9, 2018,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 90 no. 15 Supplement P6.178
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 9, 2018.
Copyright & Usage: 
© 2018

Author Disclosures

    1. Branko Huisa1,
    2. Ronald Thomas1,
    3. Shelia Jin1,
    4. Tilman Oltersdorf1,
    5. Curtis Taylor1 and
    6. Howard Feldman1
  1. Branko Huisa1,
  2. Ronald Thomas1,
  3. Shelia Jin1,
  4. Tilman Oltersdorf1,
  5. Curtis Taylor1 and
  6. Howard Feldman1
  1. 1University of California San Diego, Alzheimer Disease Cooperative Study La Jolla CA United States

Article usage

Article usage: April 2018 to July 2022

AbstractFullPdfSource
Apr 20185500Highwire
May 2018900Highwire
Jun 20181100Highwire
Jul 2018600Highwire
Aug 20181200Highwire
Sep 20181100Highwire
Oct 2018800Highwire
Nov 20181800Highwire
Dec 20181400Highwire
Jan 2019800Highwire
Feb 20191100Highwire
Mar 20191500Highwire
Apr 20191900Highwire
May 2019900Highwire
Jun 2019500Highwire
Jul 20191000Highwire
Aug 2019500Highwire
Sep 2019300Highwire
Oct 2019800Highwire
Nov 2019600Highwire
Dec 2019500Highwire
Jan 2020300Highwire
Feb 2020200Highwire
Mar 2020600Highwire
Apr 2020200Highwire
May 2020400Highwire
Jun 2020100Highwire
Jul 2020100Highwire
Sep 2020400Highwire
Oct 2020300Highwire
Nov 2020300Highwire
Dec 20202400Highwire
Jan 2021100Highwire
Feb 2021200Highwire
Mar 2021300Highwire
Apr 2021300Highwire
Jun 2021200Highwire
Jul 2021500Highwire
Aug 2021300Highwire
Sep 2021100Highwire
Oct 2021300Highwire
Nov 2021400Highwire
Dec 2021300Highwire
Jan 2022500Highwire
Feb 2022600Highwire
Mar 2022600Highwire
Apr 2022200Highwire
May 2022600Highwire
Jun 2022200Highwire
Jul 2022300Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me